Series Of Individually Immaterial Business Acquisitions
Total Consideration
$115.0M
DEERE & CO — Key Metrics
12 years of history · ending 2025-11-02 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)↓-2.6% -$0
$19
Book Value Per Share↑+62.7% +$37
$96
Free Cash Flow Per Share↑+2.5% +$1
$22
Cash Per Share↑+19.3% +$5
$30
Revenue Per Share↑+19.9% +$28
$168
OCF Per Share↑+11.6% +$3
$27
Return on Equity↓-17.4pts
20.6%
Return on Assets↓-2.8pts
4.7%
Return on Invested Capital↑+24.2pts
31.3%
Debt to Equity↓-34.1% -$1
1.78
Asset Turnover↓-22.6% -$0
0.43
Days Sales Outstanding↑+21.8% +$8
42.48
Days Inventory On Hand↓-19.8% -$2K
8447.47
R&D / Revenue↑+1.5pts
5.1%
SBC / Revenue↑+0.1pts
0.3%
Capex / Revenue↑+1.1pts
3.0%
Net Current Asset Value↓-21.8% -$14.31B
$-79.99B
Invested Capital↓-49.4% -$25.37B
$25.95B
OCF / Net Income↑+14.5% +$0
1.48
FCF / Net Income↑+5.2% +$0
1.21
Accruals Ratio (Sloan)↓-0.2pts
-2.3%
Net Debt↓-84.6% -$30.27B
$5.52B
Net Debt / EBITDA↓-30.4% -$1
2.48
Interest Coverage↓-21.8% -$1
2.70
Cash Coverage↓-69.8% -$5
2.35
Dividend Coverage↓-41.6% -$3
4.34
Capex Coverage↓-39.8% -$4
5.48
Tangible Common Equity↑+50.5% +$7.00B
$20.87B
TCE / Total Assets↑+3.2pts
19.7%
Goodwill / Total Assets↑+0.0pts
4.0%
NOPAT↑+124.9% +$3.88B
$6.98B
Cash ROIC↑+10.8pts
25.0%
Capex / D&A↑+47.5% +$0
0.61
Reinvestment Rate↑+23.3pts
-5.3%
Total Payout Ratio↓-3.2pts
56.9%
Asset Growth vs Revenue Growth↑+22.3pts
10.4%
Revenue 5Y CAGR↓-5.4pts
5.2%
EPS 5Y CAGR↓-18.6pts
12.8%
FCF 5Y CAGR↓-18.9pts
-1.8%
EBITDA 5Y CAGR↓-38.5pts
-19.1%
Book Value 5Y CAGR↓-8.2pts
14.9%
Stock Price (FY-end)↑+42.3% +$136
$459
Market Cap↑+23.1% +$23.42B
$124.63B
P/E Ratio↑+46.1% +$8
24.79
P/S Ratio↑+18.7% +$0
2.73
P/B Ratio↓-12.5% -$1
4.80
P/TB Ratio↓-18.2% -$1
5.97
P/OCF Ratio↑+27.5% +$4
16.71
P/FCF Ratio↑+38.9% +$6
20.43
Enterprise Value↓-5.0% -$6.85B
$130.15B
EV / EBITDA↑+328.8% +$45
58.39
EV / Sales↓-8.5% -$0
2.85
EV / FCF↑+7.1% +$1
21.34
FCF Yield↓-1.9pts
4.9%
Dividend Yield↑+0.4pts
1.4%
Shareholder Yield↓-1.3pts
2.2%
Buyback Yield↓-1.6pts
0.9%
R&D Yield↑+0.3pts
1.9%
Capex Yield↑+0.3pts
1.1%
Dividend Per Share↑+91.1% +$3
$6
DPS YoY Growth↓-0.4pts
9.3%
Operating Leverage↑+638.5% +$2
1.94
Graham Number↑+25.9% +$41
$199
Shares Variation (YoY)↓-1.1pts
-1.9%
Beta (5Y)↓-28.2% -$0
0.81
Cost of Equity↓-1.6pts
8.6%
Cost of Debt (after tax)↑+16.6pts
18.4%
WACC↑+1.9pts
9.5%
ROIC - WACC Spread↑+20.9pts
21.0%
52W High↑+42.1% +$155
$525
52W Low↑+81.4% +$171
$382
Trailing Return 1Y↓-36.5pts
15.3%
Trailing Return 5Y↓-219.0pts
110.2%
F-Score (Piotroski)↓-50.0% -$4
4.00
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Stock Price on Earnings Dates
DEERE & CO — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | — | — | — | — | — | — |
| Foreign Rate Differential | — | — | — | — | — | — |
| Other Adjustments | — | — | — | — | — | — |
| Effective Tax Rate | — | — | — | — | — | — |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $1.08B | $1.66B | $2.01B | $2.87B | $2.09B | $1.26B |
| Income Taxes Paid (Cash) | $1.07B | $2.08B | $1.94B | $3.58B | $2.52B | $1.65B |
DEERE & CO — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.